CARDIOVASCULAR AND RENAL ACTION OF DOPAMINERGIC PRODRUGS

被引：21

作者：

CASAGRANDE, C

MERLO, L

FERRINI, R

MIRAGOLI, G

SEMERARO, C

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1989年 / 14卷

关键词：

D O I：

10.1097/00005344-198906148-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S40 / S59

页数：20

共 110 条

[91] SUSTAINED HEMODYNAMIC IMPROVEMENT DURING LONG-TERM THERAPY WITH LEVODOPA IN HEART-FAILURE - ROLE OF PLASMA-CATECHOLAMINES [J].

RAJFER, SI ;

ROSSEN, JD ;

NEMANICH, JW ;

DOUGLAS, FL ;

DAVIS, F ;

OSINSKI, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (06) :1286-1293

[92] INHIBITION OF PROLACTIN AND ALDOSTERONE SECRETION BY THE DOPAMINE DERIVATIVE IBOPAMINE [J].

ROLANDI, E ;

MARCHETTI, G ;

FRANCESCHINI, R ;

CICCHETTI, V ;

GIANROSSI, R ;

CANTONI, V ;

BARRECA, T .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (05) :629-630

[93]

RUSSO GE, 1986, FARMACI, V10, P281

[94]

SEMERARO C, 1988, Pharmacological Research Communications, V20, P354, DOI 10.1016/S0031-6989(88)80484-3

[95] ADVERSE CLINICAL AND HEMODYNAMIC-EFFECTS OF ORAL LEVODOPA IN CHRONIC CONGESTIVE HEART-FAILURE [J].

SHAH, PK ;

AMIN, DK ;

HORN, E .

AMERICAN HEART JOURNAL, 1985, 110 (02) :488-490

[96]

SHEBUSKI RJ, 1987, J PHARMACOL EXP THER, V241, P6

[97]

SOFFIANTINO F, 1987, EUR H EART J S2, V8, P136

[98] DOPAMINERGIC MODULATION OF RENIN RELEASE [J].

SOWERS, JR ;

BARRETT, JD ;

SAMBHI, MP .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1981, 3 (01) :15-25

[99]

TANIMURA C, 1985, JPN J ACUTE MED, V9, P473

[100]

VELASCO M, 1974, PHARMACOLOGIST, V16, P268

← 2 3 4 5 6 7 8 9 10 11 →